Back to search
Primary Generalized Tonic-Clonic Seizures
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Generalized Tonic-Clonic Seizures trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Generalized Tonic-Clonic Seizures trials you may qualify forThis is a randomized trial for patients with brain metastases in the primary motor cortex who have not had seizures to receive either the prophylactic anti-seiz…
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 admini…
The purpose of this study is to determine the safety of Fycompa for injection after administration in participants with epilepsy (partial-onset seizures \[inclu…
To investigate the efficacy and safety of ONO-2017 in combination with antiepileptics in Japanese epileptic patients with generalized tonic-clonic seizures.
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures
52 Week Open-Label Safety Study of Cenobamate for Subjects who Complete YKP3089C025 (core study)
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy
The main objective of this EAP is to ensure that participants participating in Study E2007-G000-332, Study E2007-G000-311, E2007-G000-238, E2007-G000-338 or EAP…